Allisartan Isoproxil Improves Endothelial Function and Vascular Damage in Patients with Essential Hypertension: A Single-Center, Open-Label, Randomized Controlled Trial
Version 2 2020-06-23, 13:47
Version 1 2020-06-23, 13:34
figure
posted on 2020-06-23, 13:47 authored by Gaoxing Zhang, Yongqiang Fan, Yumin Qiu, Zhe Zhou, Jianning Zhang, Zhichao Wang, Yuanya Liu, Xing Liu, Jun Tao<p>The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).<br></p>
<p>© The authors, CC-BY-NC 2020.</p>
